Microbot Medical Stock Target Price
| MBOT Stock | USD 2.76 0.08 2.82% |
Microbot Medical's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Microbot Stock price.
Microbot | Target Price | Build AI portfolio with Microbot Stock |
Microbot Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Microbot Medical's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Microbot Medical could also be used in its relative valuation, which is a method of valuing Microbot Medical by comparing valuation metrics of similar companies.Microbot Medical is currently under evaluation in target price category among its peers.
Microbot Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Microbot Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Microbot Medical's managers, analysts, and investors.Environmental | Governance | Social |
Microbot Fundamentals
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.42 | ||||
| Current Valuation | 134.83 M | ||||
| Shares Outstanding | 67.16 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 8.88 % | ||||
| Number Of Shares Shorted | 4.54 M | ||||
| Price To Earning | (3.42) X | ||||
| Price To Book | 5.51 X | ||||
| EBITDA | (11.35 M) | ||||
| Net Income | (11.44 M) | ||||
| Cash And Equivalents | 9.29 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 111 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.60 X | ||||
| Book Value Per Share | 0.80 X | ||||
| Cash Flow From Operations | (8.83 M) | ||||
| Short Ratio | 0.64 X | ||||
| Earnings Per Share | (0.58) X | ||||
| Target Price | 12.0 | ||||
| Number Of Employees | 20 | ||||
| Beta | 1.25 | ||||
| Market Capitalization | 190.73 M | ||||
| Total Asset | 6.03 M | ||||
| Retained Earnings | (90.94 M) | ||||
| Working Capital | 3.36 M | ||||
| Current Asset | 15.21 M | ||||
| Current Liabilities | 9.83 M | ||||
| Net Asset | 6.03 M |
About Microbot Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Microbot Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microbot Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microbot Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.